NYU Langone Health  and Regeneron Pharmaceuticals Inc. are proud to offer an American College of Laboratory Animal Medicine (ACLAM)–recognized three-year postdoctoral training program in laboratory animal medicine. Our training program is led by eight ACLAM-boarded veterinarians and one American College of Veterinary Pathologists (ACVP)–boarded veterinary pathologist. The two participating institutions contribute to a dynamic curriculum that provides postdocs with the opportunity to work with a wide variety of species; gain an appreciation of the organizational, managerial, and operational differences between three distinctly different research institutions; and gain a broad understanding of the differences between academia and industry. Our combined experience comprehensively prepares the next generation of laboratory animal veterinarians for the many career paths available in the field. Graduates of American Veterinary Medical Association (AVMA)–accredited schools of veterinary medicine, with a strong interest in laboratory animal medicine, are encouraged to apply through the Veterinary Internship and Residency Matching Program (VIRMP).

Laboratory Animal Medicine Externship

Externship experiences are available for interested veterinary students in their first through fourth years. To apply for an externship experience, please submit a copy of your CV, a letter of interest, and three professional references to Molly M. Klores, DVM, DACLAM, program co-director, at Molly.Klores@NYULangone.org. Our externship experiences require a minimum time commitment of two weeks, and applications must be submitted atleast four months in advance to allow for adequate processing time. Externship opportunities are available for qualified applicants on a first-come, first-served basis.

Participating Institutions

NYU Langone, an academic medical center leads research, teaching, and testing programs that include neuroscience and behavior, microbiology, immunology, cancer, cardiology, surgery, diagnostic imaging, and endocrinology. NYU Grossman School of Medicine is part of NYU Langone. Regeneron is a leading science-based, fully integrated biopharmaceutical company that discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases and colorectal cancer, among other conditions, and has product candidates in development in areas of high unmet medical need such as hypercholesterolemia, rheumatoid arthritis, and asthma. Most recently, Regeneron successfully developed an antibody cocktail against Ebola and against coronavirus disease (COVID-19).

Contact Us

For general inquiries about our training program, please email Dr. Klores at Molly.Klores@NYULangone.org.